GO:0015914 phospholipid transport: Membrane Lipid Distribution, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0015914 phospholipid transport describes the directed movement of phospholipids into, out of, or within a cell, or between cells, by means of transporters or pores.
Phospholipid transport is essential for membrane biogenesis, lipid asymmetry, and organelle identity, and defects are linked to metabolic, cardiovascular, and neurodegenerative disease [1,2,3].
Key proteins include ABCA1, ABCA7, MDR3/ABCB4, and mitochondrial translocators such as PRELID1/TRIAP1, which move phospholipids between membranes [2,3].
Choline and glycerophosphodiester transporters supply precursors for phospholipid synthesis and recycling, coupling transport to phosphatidylcholine homeostasis [5,6,7].
Phospholipid methylation and transport intersect with calcium transport efficiency and muscle metabolic rate, illustrating cross-pathway regulation.
CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of phospholipid transport genes in human cells and organoids [1,2,3].

Description

Phospholipid transport (GO:0015914) is the directed movement of phospholipids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Phospholipids are amphipathic molecules containing phosphoric acid as a mono- or diester, and their asymmetric distribution across membranes is fundamental to cell signaling, vesicle trafficking, and organelle function. Because phospholipids are synthesized primarily in the endoplasmic reticulum and mitochondria, their delivery to the plasma membrane, Golgi, and other compartments requires dedicated transport pathways [1,2]. Research on phospholipid transport spans ATP-binding cassette (ABC) transporters, mitochondrial membrane contact sites, choline and glycerophosphodiester uptake systems, and lipid transfer proteins [2,3,5,6,7]. Defects in these pathways contribute to Tangier disease, cholestasis, neurodegeneration, and metabolic disorders, making this GO term a high-value target for functional genomics [3,5,8]. Understanding the molecular players and regulatory logic of phospholipid transport is therefore central to membrane biology and therapeutic development [1,2,8].

phospholipid transport At A Glance

GO ID GO:0015914
GO term phospholipid transport
Ontology biological_process
Synonym none
Major function Directed movement of phospholipids across or between membranes via transporters, pores, or transfer proteins
Definition source QuickGO definition
Related processes Membrane biogenesis, lipid asymmetry, lipoprotein metabolism, mitochondrial lipid transfer
Representative genes ABCA1, ABCA7, ABCB4, PRELID1, TRIAP1, SLC44A1, SLC44A2, PLSCR1
Disease relevance Tangier disease, cholestasis, neurodegeneration, metabolic disorders

What Is GO:0015914?

GO:0015914 phospholipid transport is defined as the directed movement of phospholipids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Phospholipids are any lipids containing phosphoric acid as a mono- or diester. This biological process encompasses protein-mediated translocation across bilayers, transfer between organelle membranes, and secretion or uptake of phospholipid species [1,2,3].

Why Is phospholipid transport Important in Cell Biology?

Phospholipid transport is essential because membranes cannot self-assemble without directed lipid delivery, and the asymmetric distribution of phospholipids controls signaling, curvature, and vesicle formation. Disruption of phospholipid transport alters cholesterol efflux, bile composition, mitochondrial function, and calcium handling, with consequences for cardiovascular, hepatic, and neuromuscular disease [2,3,8]. As a result, genes annotated to GO:0015914 are priority candidates for functional validation in human cell models [1,2,3].
Maintains phospholipid asymmetry required for membrane integrity and signaling.
Supports lipoprotein assembly and reverse cholesterol transport via ABCA1.
Enables mitochondrial phospholipid import and cristae organization.
Provides choline and glycerophosphodiester precursors for phosphatidylcholine synthesis [5,6,7].
Links phospholipid methylation to calcium transport efficiency and muscle metabolic rate.
Underlies bile phospholipid secretion through ABCB4/MDR3.
Contributes to neuronal membrane homeostasis and neurodegeneration risk.
Serves as a druggable node in metabolic and cardiovascular disease [3,8].
Provides mechanistic insight into synthetic foldamer-mediated bilayer transport.
Enables CRISPR-based causal screens for lipid trafficking regulators [1,2].

What Happens During phospholipid transport?

Phospholipid synthesis and membrane insertion
In simple terms: Cells first make phospholipids in the endoplasmic reticulum and mitochondria, then insert them into membranes.
Phospholipid synthesis occurs mainly in the endoplasmic reticulum, with additional mitochondrial pathways, and newly synthesized lipids are inserted into the cytosolic or luminal leaflet of the membrane [1,2]. This step establishes the pool of phospholipids available for subsequent transport and is tightly coupled to membrane expansion.
Transporter-mediated translocation across bilayers
In simple terms: Special proteins flip or pump phospholipids from one side of a membrane to the other.
ABC transporters such as ABCA1 and ABCB4 mediate ATP-dependent translocation of phospholipids across the plasma membrane and canalicular membrane, respectively [1,3]. The extracellular translocase or alternating access model describes how ABCA1 exposes phospholipids to extracellular acceptors such as apolipoprotein A-I. Synthetic foldamers can also facilitate phospholipid bilayer transport, highlighting the biophysical principles involved.
Inter-organelle lipid transfer
In simple terms: Lipids are shuttled between organelles at contact sites without fully entering the cytosol.
Mitochondria receive phospholipids through membrane contact sites and dedicated transfer proteins, including PRELID1/TRIAP1 complexes that move phosphatidic acid and phosphatidylserine. These transfer events are essential for mitochondrial membrane biogenesis and cristae architecture.
Precursor uptake for phospholipid synthesis
In simple terms: Cells import choline and glycerophosphodiesters that are used to build or recycle phospholipids.
Choline transporter-like protein 1 (SLC44A1) and related transporters supply choline for phosphatidylcholine synthesis [5,6]. Glycerophosphodiester transporters recycle deacylation products back into phospholipid metabolism. This precursor uptake is rate-limiting for phospholipid production in many cell types [5,6,7].
Phospholipid methylation and functional coupling
In simple terms: Methylation of phospholipids can change membrane properties and affect other transport systems.
Phospholipid methylation regulates muscle metabolic rate through modulation of calcium transport efficiency, demonstrating that phospholipid transport and methylation are functionally coupled to ion homeostasis. This cross-talk illustrates how phospholipid transport influences systemic physiology beyond membrane structure.

Key Genes Involved in GO:0015914 phospholipid transport

The following genes and proteins are experimentally implicated in phospholipid transport (GO:0015914) and related pathways.
GeneMajor RoleResearch Relevance
ABCA1ATP-dependent phospholipid and cholesterol efflux to apoA-ITangier disease, HDL biogenesis, reverse cholesterol transport
ABCA7Phospholipid transport in brain and immune cellsAlzheimer disease risk, microglial lipid handling
ABCB4 (MDR3)Canalicular phosphatidylcholine secretionProgressive familial intrahepatic cholestasis
PRELID1Mitochondrial phosphatidic acid transferMitochondrial membrane biogenesis
TRIAP1PRELID1 partner in lipid transferMitochondrial lipid import, apoptosis regulation
SLC44A1Choline transporter-like protein 1Phosphatidylcholine synthesis, choline uptake
SLC44A2Choline transporter-like protein 2Choline transport for phospholipid synthesis
PLSCR1Phospholipid scramblaseMembrane asymmetry, apoptosis
ATP8B1Aminophospholipid flippaseCholestasis, membrane asymmetry
ATP11AP4-ATPase flippasePhosphatidylserine asymmetry
ATP11BP4-ATPase flippaseEndosomal phospholipid transport
CCTalphaPhosphatidylcholine synthesis enzymeRate-limiting for PC production
PEMTPhosphatidylethanolamine N-methyltransferasePhospholipid methylation, muscle metabolism
MFSD2ALysophospholipid transporterBrain lipid uptake, blood-brain barrier
NPC1Endosomal cholesterol and phospholipid traffickingNiemann-Pick disease type C
VPS13ALipid transfer at contact sitesChorea-acanthocytosis, membrane homeostasis
CERTCeramide transfer proteinSphingolipid and phospholipid homeostasis

How Is phospholipid transport Regulated?

Phospholipid transport is regulated at multiple levels. Substrate availability of choline and glycerophosphodiesters controls flux through phosphatidylcholine synthesis pathways [5,6,7]. ABCA1-mediated phospholipid efflux is regulated by apolipoprotein acceptors and cellular cholesterol status. Mitochondrial phospholipid transfer via PRELID1/TRIAP1 is coupled to mitochondrial bioenergetic state and apoptosis. Phospholipid methylation by PEMT modulates calcium transport efficiency and muscle metabolic rate, providing a regulatory link between lipid modification and ion homeostasis. These layers of regulation ensure that phospholipid distribution adapts to metabolic demand and membrane remodeling [1,8].

phospholipid transport and Human Disease

GeneDisease / BiologyPotential Experimental Model
ABCA1Tangier disease, HDL deficiencyABCA1 knockout HEK293 or macrophage cell line
ABCB4Progressive familial intrahepatic cholestasisABCB4 knockout hepatocyte-like cells
ABCA7Alzheimer disease riskABCA7 knockout microglial cells
PEMTMuscle metabolic rate regulationPEMT knockout myotubes
SLC44A1Choline transport deficiencySLC44A1 knockout neuronal cells
Tangier disease and HDL deficiency
Loss-of-function mutations in ABCA1 impair phospholipid and cholesterol efflux to apolipoprotein A-I, causing Tangier disease and very low HDL levels. The extracellular translocase or alternating access model explains how ABCA1 presents phospholipids to extracellular acceptors, and its disruption leads to lipid accumulation in macrophages.
Cholestasis and liver disease
ABCB4/MDR3 mediates canalicular phosphatidylcholine secretion, and its dysfunction causes progressive familial intrahepatic cholestasis. Impaired phospholipid transport in hepatocytes alters bile composition and promotes liver injury.
Neurodegeneration and brain lipid homeostasis
ABCA7 and MFSD2A participate in brain phospholipid transport, and their dysfunction is linked to Alzheimer disease risk and blood-brain barrier lipid uptake defects. Mitochondrial phospholipid transfer proteins also influence neuronal survival through membrane remodeling.
Metabolic and muscle disorders
Phospholipid methylation regulates muscle metabolic rate through calcium transport efficiency, linking phospholipid transport and modification to systemic energy metabolism. Choline transporter defects can alter phosphatidylcholine synthesis and membrane composition in metabolic tissues [5,6].

From phospholipid transport-Related Genes to Experimental Models

Research QuestionSuitable Model
Is ABCA1 required for phospholipid efflux?ABCA1 knockout HEK293 or macrophage cells
Does a point mutation in ABCB4 alter substrate specificity?ABCB4 point-mutation knock-in hepatocyte model
Can PRELID1-TRIAP1 interaction be visualized?Tagged knock-in of PRELID1 in HeLa cells
Does SLC44A1 overexpression increase choline uptake?SLC44A1 overexpression in neuronal cell lines
Which genes regulate phospholipid transport genome-wide?CRISPR library screening in lipid-reporting cells
Does PEMT methylation affect calcium transport?PEMT knockout muscle cells

How to Study the phospholipid transport Process

MethodWhat It MeasuresTypical Application
Lipidomics (LC-MS)Phospholipid species and abundanceQuantifying transport defects
Fluorescent lipid imagingReal-time lipid movementLive-cell transport assays [1,4]
Proteoliposome transport assayATP-dependent translocationABC transporter mechanism
CRISPR knockout screenGene requirement for lipid transportGenome-wide discovery
RNA-seqTranscriptional response to lipid stressPathway analysis
ProteomicsProtein interactions in transport complexesPRELID1-TRIAP1 interactome
Metabolic flux analysisPrecursor incorporation into phospholipidsCholine and glycerophosphodiester uptake [5,6,7]
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics quantifies phospholipid species and their subcellular distribution, enabling direct measurement of transport defects [1,2]. Stable isotope labeling can trace phospholipid flux between compartments.
Fluorescent lipid analogs and imaging
Fluorescent phospholipid analogs such as NBD-labeled lipids allow live-cell imaging of transport and membrane asymmetry [1,4]. Confocal and super-resolution microscopy reveal organelle-specific lipid delivery.
Transport assays with isolated membranes
Isolated membrane vesicles and proteoliposome reconstitution measure ATP-dependent phospholipid translocation by ABC transporters. These assays define substrate specificity and kinetics.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens coupled with lipid reporters identify genes required for phospholipid transport. Bioinformatics analysis of screening hits maps candidates to GO:0015914 and related pathways [1,2].

How CRISPR Can Be Used to Study GO:0015914 phospholipid transport

Knockout

CRISPR knockout of ABCA1, ABCB4, or SLC44A1 provides causal evidence for their role in phospholipid transport and reveals compensatory pathways [1,3,5]. Knockout cell lines are used for lipidomics and transport assays.

Point Mutation

Point-mutation knock-in models mimic disease-associated missense variants in ABCA1 or ABCB4, allowing structure-function analysis of transport activity [3,1]. These models help distinguish loss-of-function from dominant-negative effects.

Knock-in

Tagged knock-in of PRELID1 or TRIAP1 enables live-cell imaging of mitochondrial phospholipid transfer complexes. Endogenous tagging preserves physiological regulation.

Overexpression

Overexpression of SLC44A1 or ABCA1 increases phospholipid transport capacity and can rescue lipid defects in disease models [5,3]. Overexpression systems are useful for biochemical purification and transport assays.

How EDITGENE Supports phospholipid transport Research

Researchers studying phospholipid transport-related genes often need to determine whether a candidate gene is causally involved in lipid movement, membrane homeostasis, or disease phenotypes. EDITGENE provides publication-ready CRISPR cell models and screening services to test these hypotheses directly in human cells.
Contact EDITGENE today to design your custom CRISPR model for phospholipid transport research.

Frequently Asked Questions About phospholipid transport

GO:0015914 phospholipid transport is the directed movement of phospholipids into, out of, or within a cell, or between cells, by means of transporters or pores.
Key genes include ABCA1, ABCA7, ABCB4, PRELID1, TRIAP1, SLC44A1, SLC44A2, PLSCR1, and PEMT [1,2,3,5,8].
It maintains membrane asymmetry, supports organelle biogenesis, and enables lipoprotein metabolism and signaling [1,2,3].
Common methods include lipidomics, fluorescent lipid imaging, proteoliposome transport assays, and CRISPR screens [1,3,4].
Tangier disease, cholestasis, Alzheimer disease risk, and metabolic muscle disorders [1,3,8].
ABCA1 mediates ATP-dependent phospholipid efflux to apolipoprotein A-I, a key step in HDL biogenesis.
Choline transporters such as SLC44A1 supply choline for phosphatidylcholine synthesis [5,6].
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of transport genes [1,2,3].
PRELID1 and TRIAP1 mediate phospholipid transfer into mitochondria at membrane contact sites.
Phospholipid methylation regulates muscle metabolic rate through calcium transport efficiency.

Conclusion

GO:0015914 phospholipid transport is a fundamental biological process that governs membrane lipid distribution, organelle function, and systemic metabolism. Its molecular players, including ABC transporters, mitochondrial transfer proteins, and choline transporters, are linked to major human diseases such as Tangier disease, cholestasis, and neurodegeneration [1,2,3,5,8]. CRISPR-based functional genomics now provides a direct route to test causality and discover new therapeutic targets in this pathway [1,2,3].

References

  1. 1. Vance JE. 2015. Phospholipid synthesis and transport in mammalian cells.. Traffic 16(1):1-18 PMID: 25243850
  2. 2. Tamura Y et al.. 2014. Phospholipid transport via mitochondria.. Traffic 15(9):933-45 PMID: 24954234
  3. 3. Segrest JP et al.. 2023. Phospholipid transport by ABCA1: the extracellular translocase or alternating access model?. Curr Opin Lipidol 34(5):208-213 PMID: 37548415
  4. 4. Zubair I et al.. 2025. Foldamer-mediated transport across phospholipid bilayers.. Curr Opin Chem Biol 84:102549 PMID: 39616809
  5. 5. Hedtke V et al.. 2019. Choline transport for phospholipid synthesis: An emerging role of choline transporter-like protein 1.. Exp Biol Med (Maywood) 244(8):655-662 PMID: 30776907
  6. 6. Michel V et al.. 2006. Choline transport for phospholipid synthesis.. Exp Biol Med (Maywood) 231(5):490-504 PMID: 16636297
  7. 7. Patton-Vogt J. 2007. Transport and metabolism of glycerophosphodiesters produced through phospholipid deacylation.. Biochim Biophys Acta 1771(3):337-42 PMID: 16781190
  8. 8. Verkerke ARP et al.. 2019. Phospholipid methylation regulates muscle metabolic rate through Ca(2+) transport efficiency.. Nat Metab 1(9):876-885 PMID: 32405618
Contact Us
*
*
*
*
How did you hear about us: